Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Vendramini-Costa DB"'
Autor:
Vendramini-Costa DB, Francescone R, Franco-Barraza J, Luong T, Graves M, de Aquino AM, Steele N, Gardiner JC, Dos Santos SAA, Ogier C, Malloy E, Borghaei L, Martinez E, Zhigarev DI, Tan Y, Lee H, Zhou Y, Cai KQ, Klein-Szanto AJ, Wang H, Andrake M, Dunbrack RL, Campbell K, Cukierman E
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 May 18. Date of Electronic Publication: 2024 May 18.
Autor:
Franco-Barraza J, Luong T, Wong JK, Raghavan K, Handorf E, Vendramini-Costa DB, Francescone R, Gardiner JC, Meyer JE, Cukierman E
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jan 15. Date of Electronic Publication: 2024 Jan 15.
Autor:
Francescone R; Department of Surgery, Henry Ford Health, Detroit, Michigan; Henry Ford Pancreatic Cancer Center, Henry Ford Health, Detroit, Michigan., Crawford HC; Department of Surgery, Henry Ford Health, Detroit, Michigan; Henry Ford Pancreatic Cancer Center, Henry Ford Health, Detroit, Michigan., Vendramini-Costa DB; Department of Surgery, Henry Ford Health, Detroit, Michigan; Henry Ford Pancreatic Cancer Center, Henry Ford Health, Detroit, Michigan. Electronic address: dbarbos1@hfhs.org.
Publikováno v:
Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2024; Vol. 17 (5), pp. 737-743. Date of Electronic Publication: 2024 Feb 03.
Autor:
Dudgeon C; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Casabianca A; Department of Surgery, Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; Wilmot Cancer Center, University of Rochester, Rochester, NY, USA., Harris C; Department of Surgery, Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; Wilmot Cancer Center, University of Rochester, Rochester, NY, USA., Ogier C; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Bellina M; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008 Lyon, France; Netris Pharma, 69008 Lyon, France., Fiore S; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008 Lyon, France., Bernet A; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008 Lyon, France; Netris Pharma, 69008 Lyon, France., Ducarouge B; Netris Pharma, 69008 Lyon, France., Goldschneider D; Netris Pharma, 69008 Lyon, France., Su X; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Pitarresi J; Department of Medicine, Division of Hematology/Oncology, University of Massachusetts, Worcester, MA, USA., Hezel A; Department of Medicine, Division of Medical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., De S; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Narrow W; Department of Surgery, Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; Wilmot Cancer Center, University of Rochester, Rochester, NY, USA., Soliman F; Rutgers Robert Wood-Johnson Medical School, New Brunswick, NJ, USA., Shields C; Wilmot Cancer Center, University of Rochester, Rochester, NY, USA., Vendramini-Costa DB; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Prela O; Department of Surgery, Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Wang L; Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA., Astsaturov I; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Mehlen P; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue,' LabEx DEVweCAN, Institut Convergence PLAsCAN, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008 Lyon, France; Netris Pharma, 69008 Lyon, France., Carpizo DR; Department of Surgery, Division of Surgical Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; Wilmot Cancer Center, University of Rochester, Rochester, NY, USA. Electronic address: darren_carpizo@urmc.rochester.edu.
Publikováno v:
Cell reports [Cell Rep] 2023 Nov 28; Vol. 42 (11), pp. 113369. Date of Electronic Publication: 2023 Nov 03.
Autor:
Ogier C, Solomon AMC, Lu Z, Recoules L, Klochkova A, Gabitova-Cornell L, Bayarmagnai B, Restifo D, Surumbayeva A, Vendramini-Costa DB, Deneka AY, Francescone R, Lilly AC, Sipman A, Gardiner JC, Luong T, Franco-Barraza J, Ibeme N, Cai KQ, Einarson MB, Nicolas E, Efimov A, Megill E, Snyder NW, Bousquet C, Cros J, Zhou Y, Golemis EA, Gligorijevic B, Soboloff J, Fuchs SY, Cukierman E, Astsaturov I
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 17. Date of Electronic Publication: 2023 Sep 17.
Autor:
Raghavan KS; Doctoral program in Molecular Cell Biology and Genetics, Drexel University College of Medicine, Philadelphia, PA, USA.; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Francescone R; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Franco-Barraza J; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Gardiner JC; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Vendramini-Costa DB; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Luong T; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Pourmandi N; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA., Andren A; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA., Kurimchak A; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Ogier C; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Campbell PM; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Duncan JS; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Lyssiotis CA; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA., Languino LR; Prostate Cancer Discovery and Development Program, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Cukierman E; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Sep; Vol. 2 (9), pp. 1017-1036. Date of Electronic Publication: 2022 Sep 19.
Autor:
de Lima CA; Research Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista, SP, Brazil.; Graduate Program in Health Science, São Francisco University, Bragança Paulista, SP, Brazil., Cubero MCZ; Research Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista, SP, Brazil.; Graduate Program in Health Science, São Francisco University, Bragança Paulista, SP, Brazil., Franco YEM; Research Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista, SP, Brazil.; Graduate Program in Health Science, São Francisco University, Bragança Paulista, SP, Brazil., Rodrigues CDP; Natural Products Chemistry Laboratory-Department of Chemistry-Federal University of Maranhão (UFMA), São Luís, MA, Brazil., do Nascimento JR; Natural Products Chemistry Laboratory-Department of Chemistry-Federal University of Maranhão (UFMA), São Luís, MA, Brazil., Vendramini-Costa DB; Cancer Signaling and Epigenetics Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Sciani JM; Graduate Program in Health Science, São Francisco University, Bragança Paulista, SP, Brazil.; Laboratory of Multidisciplinary Research, São Francisco University (USF), Bragança Paulista, SP, Brazil., da Rocha CQ; Natural Products Chemistry Laboratory-Department of Chemistry-Federal University of Maranhão (UFMA), São Luís, MA, Brazil., Longato GB; Research Laboratory in Molecular Pharmacology of Bioactive Compounds, São Francisco University (USF), Bragança Paulista, SP, Brazil.; Graduate Program in Health Science, São Francisco University, Bragança Paulista, SP, Brazil.
Publikováno v:
BioMed research international [Biomed Res Int] 2022 Feb 11; Vol. 2022, pp. 3319203. Date of Electronic Publication: 2022 Feb 11 (Print Publication: 2022).
Autor:
Francescone R; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA. ralph.francescone@fccc.edu.; Marvin and Concetta Greenberg, Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA. ralph.francescone@fccc.edu., Vendramini-Costa DB; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg, Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2514, pp. 31-38.
Autor:
Francescone R; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA. ralph.francescone@fccc.edu.; Marvin and Concetta Greenberg, Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA. ralph.francescone@fccc.edu., Vendramini-Costa DB; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg, Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2514, pp. 15-28.
Autor:
Alexander JI; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA.; Molecular, Cellular Biology and Genetics Program, College of Medicine, Drexel University, Philadelphia, PA, USA., Vendramini-Costa DB; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Francescone R; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Luong T; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Franco-Barraza J; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Shah N; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Gardiner JC; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Nicolas E; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA., Raghavan KS; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA.; Molecular, Cellular Biology and Genetics Program, College of Medicine, Drexel University, Philadelphia, PA, USA., Cukierman E; Cancer Biology and the Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA. edna.cukierman@fccc.edu.
Publikováno v:
Scientific reports [Sci Rep] 2021 Feb 15; Vol. 11 (1), pp. 3802. Date of Electronic Publication: 2021 Feb 15.